| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Endocrinology, Department of Pediatrics, Sophia Childrens Hospital (A.L.M.B., S.L.S.D.), Rotterdam; Wilhelmina Childrens Hospital (M.A.V.), Utrecht; University Hospital Nijmegen (B.J.O.), Nijmegen; University Hospital Groningen (C.W.R.), Groningen; Free University Hospital Amsterdam (H.A.D.W.), Amsterdam; the Department of Endocrinology and Reproduction, Erasmus University (A.L.M.B., A.O.B., F.H.J., P.E.R.), Rotterdam; Department of Clinical Genetics, University Hospital Rotterdam and Erasmus University (A.L.M.B., L.A.S., D.J.J.H., M.F.N.), Rotterdam; the Department of Internal Medicine III, University Hospital Rotterdam (F.H.J.);, Rotterdam, The Netherlands; The Netherlands; Cecil H. and Ida Green Center for Reproductive Biological Sciences, University of Texas Southwestern Medical Center (S.A), Dallas, Texas 75235; the Division of Endocrinology, Department of Pediatrics, Medical Genetics Division, Institute of Child Health, Istanbul Medical Faculty, University of Istanbul (H.K.), Istanbul, Turkey; the Developmental Endocrinology Unit, Division of Endocrinology, Hospital das Clinicas, University of Sao Paulo (B.B.M.), Sao Paulo, Brazil; Hospital Maria Pia (C.R.), Porto, Portugal; and the Department of Pediatric Endocrinology, Sydney Childrens Hospital (H.H.B.), Randwick, Australia
Address all correspondence and requests for reprints to: Dr. Annemie L. M. Boehmer, M.D., Department of Pediatrics, Division of Endocrinology, Sophia Childrens Hospital, P.O. Box 2060, 3000 CB Rotterdam, The Netherlands. E-mail: boehmer{at}ALKG.AZR.NL
17ß-Hydroxysteroid dehydrogenase-3 (17ßHSD3) deficiency is an autosomal recessive form of male pseudohermaphroditism caused by mutations in the HSD17B3 gene. In a nationwide study on male pseudohermaphroditism among all pediatric endocrinologists and clinical geneticists in The Netherlands, 18 17ßHSD3-deficient index cases were identified, 12 of whom initially had received the tentative diagnosis androgen insensitivity syndrome (AIS). The phenotypes and genotypes of these patients were studied. Endocrine diagnostic methods were evaluated in comparison to mutation analysis of the HSD17B3 gene. RT-PCR studies were performed on testicular ribonucleic acid of patients homozygous for two different splice site mutations. The minimal incidence of 17ßHSD3 deficiency in The Netherlands and the corresponding carrier frequency were calculated. Haplotype analysis of the chromosomal region of the HSD17B3 gene in Europeans, North Americans, Latin Americans, Australians, and Arabs was used to establish whether recurrent identical mutations were ancient or had repeatedly occurred de novo.
In genotypically identical cases, phenotypic variation for
external sexual development was observed. Gonadotropin-stimulated serum
testosterone/androstenedione ratios in 17ßHSD3-deficient patients
were discriminative in all cases and did not overlap with ratios in
normal controls or with ratios in AIS patients. In all investigated
patients both HSD17B3 alleles were mutated. The intronic mutations 325
+ 4;A
T and 6551;G
A disrupted normal splicing, but a small
amount of wild-type messenger ribonucleic acid was still made in
patients homozygous for 6551;G
A. The minimal incidence of
17ßHSD3 deficiency in The Netherlands was shown to be 1:147,000, with
a heterozygote frequency of 1:135. At least 4 mutations, 325 + 4;A
T,
N74T, 6551;G
A, and R80Q, found worldwide, appeared to be ancient
and originating from genetic founders. Their dispersion could be
reconstructed through historical analysis. The HSD17B3 gene mutations
3261;G
C and P282L were de novo mutations.
17ßHSD3 deficiency can be reliably diagnosed by endocrine evaluation and mutation analysis. Phenotypic variation can occur between families with the same homozygous mutations. The incidence of 17ßHSD3 deficiency is 0.65 times the incidence of AIS, which is thought to be the most frequent known cause of male pseudohermaphroditism without dysgenic gonads. A global inventory of affected cases demonstrated the ancient origin of at least four mutations. The mutational history of this genetic locus offers views into human diversity and disease, provided by national and international collaboration.
This article has been cited by other articles:
![]() |
T S Han, D Goswami, S Trikudanathan, S M Creighton, and G S Conway Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis Eur. J. Endocrinol., August 1, 2008; 159(2): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bouvattier, B. Mignot, H. Lefevre, Y. Morel, and P. Bougneres Impaired Sexual Activity in Male Adults with Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3310 - 3315. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rey, E. Codner, G. Iniguez, P. Bedecarras, R. Trigo, C. Okuma, S. Gottlieb, I. Bergada, S. M. Campo, and F. G. Cassorla Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6035 - 6040. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Umar, C. A. Berrevoets, N. M. Van, M. van Leeuwen, M. Verbiest, W. J. Kleijer, D. Dooijes, J. A. Grootegoed, S. L. S. Drop, and A. O. Brinkmann Functional Analysis of a Novel Androgen Receptor Mutation, Q902K, in an Individual with Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Migeon, A. B. Wisniewski, J. P. Gearhart, H. F.L. Meyer-Bahlburg, J. A. Rock, T. R. Brown, S. J. Casella, A. Maret, K. M. Ngai, J. Money, et al. Ambiguous Genitalia With Perineoscrotal Hypospadias in 46,XY Individuals: Long-Term Medical, Surgical, and Psychosexual Outcome Pediatrics, September 1, 2002; 110(3): e31 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Migeon, A. B. Wisniewski, T. R. Brown, J. A. Rock, H. F. L. Meyer-Bahlburg, J. Money, and G. D. Berkovitz 46,XY Intersex Individuals: Phenotypic and Etiologic Classification, Knowledge of Condition, and Satisfaction With Knowledge in Adulthood Pediatrics, September 1, 2002; 110(3): e32 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. M. Boehmer, H. Bruggenwirth, C. van Assendelft, B. J. Otten, M. C. T. Verleun-Mooijman, M. F. Niermeijer, H. G. Brunner, C. W. Rouwe, J. J. Waelkens, W. Oostdijk, et al. Genotype Versus Phenotype in Families with Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4151 - 4160. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Hughes Minireview: Sex Differentiation Endocrinology, August 1, 2001; 142(8): 3281 - 3287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lindqvist, I. A. Hughes, and S. Andersson Substitution Mutation C268Y Causes 17{beta}-Hydroxysteroid Dehydrogenase 3 Deficiency J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 921 - 923. [Abstract] [Full Text] |
||||
![]() |
P.-M. Holterhus, G. H. G. Sinnecker, and O. Hiort Phenotypic Diversity and Testosterone-Induced Normalization of Mutant L712F Androgen Receptor Function in a Kindred with Androgen Insensitivity J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3245 - 3250. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |